
Jill S. Waibel
Articles
-
1 month ago |
healio.com | Rebecca Forand |Jill S. Waibel
Key takeaways: Burn and trauma scars can be extensive and difficult for patients. Jill S. Waibel, MD, gives pearls on how to best approach these cases. ORLANDO — Innovations in treating burn and trauma scars in recent years include updated laser technology, giving practitioners options to help in these difficult cases, according to a speaker here. “When I look at a scar, I think about un-coloring a picture. What do I want it to look like when I’m done?” Jill S.
-
Mar 19, 2024 |
healio.com | Rebecca Forand |Kristen Dowd |Jill S. Waibel
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The phase 3b ADmirable trial is the first to evaluate lebrikizumab in patients with skin of color. Interim results showed EASI and IGA improvement after 16 weeks of treatment with lebrikizumab.
-
Mar 11, 2024 |
dermatologytimes.com | Emma Andrus |Jill S. Waibel
At the 2024 American Academy of Dermatology Annual Meeting in San Diego, California, Jill Waibel, MD, presented sessions on the topic of laser and other modalities for the treatment of various types of scarring. Waibel, the chief of dermatology for Baptist Hospital and inpatients and a clinical voluntary assistant professor at the University of Miami, owns 2 private practices in Miami, Florida.
-
Feb 13, 2023 |
healio.com | Gabrielle Capaldo |Kristen Dowd |Jill S. Waibel
Source/Disclosures Source: Waibel JS, et al. Cosmetic derm + genomics: The future. Presented at: South Beach Symposium; Feb. 9-10, 2023; Miami Beach, Fla. Disclosures: Waibel reports being a speaker, investigator or consultant for AbbVie, argenx, Cytrellis, Dominion Aesthetic Technologies, Eli Lilly, L’Oréal, Lumenis, Lutronic, Michelson Diagnostics, Novartis, Pfizer, RegenX, Reactive, Sciton, Syneron/Candela, Turn Biotechnologies and UCB.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →